MedPath

Effects of behavioral activation therapy on some treatment parameters in breast cancer wome

Phase 2
Conditions
Breast Cancer.
Carcinoma in situ of breast, unspecified
Registration Number
IRCT2017100817756N31
Lead Sponsor
Vice-Chancellery for Research and Technology, Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Female patients over 18 years of age; breast cancer grade 2 or 3 confirmed by the oncologist; patient having undergone mastectomy; patient currently undergoing chemotherapy; simultaneous experience of demoralization along with breast cancer; lack of previous or concurrent participation in psychological interventions; no previous experience of behavioral activation intervention; chemotherapy-induced nausea and vomiting; non-compliance with treatment; completing the written consent form for participation in the psychological intervention.
Exclusion criteria: Patient's death during Intervention; unwillingness to continue collaboration in the research; failure to do homework or exercises; and absence from intervention and treatment for 2 sessions or more.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adherence to treatment. Timepoint: Before and after intervention. Method of measurement: Morisky Medication Adherence Scale.;Serum levels of cancer markers. Timepoint: Before and after intervention. Method of measurement: laboratory results.;Chemotherapy-induced nausea and vomiting. Timepoint: before and after intervention. Method of measurement: Index of Nausea, Vomiting, and Retching.;Demoralization. Timepoint: Before and after intervention. Method of measurement: Demoralization Scale by Kissane et al. (2004).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath